News

New publication

PMBL™ reduces hospitalization time

December 17th,2015- Massagno, Switzerland—Results of a multicentre, double-blind, randomised, controlled, phase IV study in Chronic Obstructive Pulmonary Disease(COPD)[...][...] [+]

Letter

Respiratory Health is already affected by climate change

  December 11, 2015-Massagno, Switzerland_ As COP21 conference is drawig to an end in Paris, th World Health Organizatio (WHO), estimates that some 250,000 additional[...][...] [+]

New publication

PMBL™ Contest arrived and the winners are…

June 16th-18th, 2015 …Ms Natalya Kolpokova, from Stada CIS (Russia), and Mr Jan Oryl, from GSK Poland were the happy winners of Lallemand Pharma PMBL™ Contest. PMBL™[...][...] [+]

New Launch

LALLEMAND PHARMA AND MERCK CONTINUE ISMIGEN® MARKETING IN LATIN AMERICA

November 19th, 2014- Massagno, Switzerland — Spurred by the success of ISMIGEN® in Latin America, Lallemand Pharma and Merck are pleased to announce the launch in Dominican[...][...] [+]

 
More news
 

Calendar of events

December 12, 2013

1st International Workshop on Lung Health, COPD: The new paradigms- MONACO

Lallemand Pharma is proud to announce sponsored workshop on PMBL as regards to the latest clinical results in AECOPD during the 1st International Workshop on Lung Health, COPD:[...][...] [+]

September 13, 2013

15th Anniversary Conference for Allergists, Pulmonologists and Clinical ...

Lallemand Pharma is proud to announce full session on PMBL during the 15th Anniversary Conference for Allergists, Pulmonologists and Clinical Immunologists in Kazimierz in[...][...] [+]

 
More events